Literature DB >> 31377717

Refractory Burkholderia cepacia bacteraemia from a consolidation pneumonia lasting more than 7 weeks, successfully treated with systemic antibiotics and nebulised meropenem.

Bryan Albert Lim1, Adelaine Lopez1, Joseph Adrian Buensalido1.   

Abstract

We present a case of a 55-year-old Filipino man who was transferred from another institution where he was recently diagnosed with Crohn's disease but not started on any immunosuppressants. He underwent laparoscopic cholecystectomy with T-tube placement a few weeks prior to admission. On workup, abdominal CT scan was unremarkable, but blood cultures on the third hospital day grew Burkholderia cepacia Antibiotic regimen was shifted to ceftazidime and levofloxacin. The bacteraemia and febrile episodes persisted despite removal of the central line and T tube. White blood cell scan and chest CT scan showed left-sided consolidation pneumonia. Blood cultures continued to grow B. cepacia despite shifting to meropenem and trimethoprim-sulfamethoxazole. Meropenem nebulisation at 250 mg every 12 hours was added to the regimen on the third week then oral minocycline was added on the fourth week due to persistence of bacteraemia. He subsequently developed a small vegetation on the aortic valve, so amikacin was added. Fever lysed on the sixth week, but the B. cepacia bacteraemia persisted, clearing only on the 51st hospital day. The patient was discharged with a plan to continue antibiotics, including meropenem nebulisation, for 6 more weeks. On follow-up, the patient had no recurrence of fever. There was also resolution of consolidation on chest CT scan and disappearance of vegetation on echocardiography. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: infectious diseases; infections; infectious diseases; pneumonia (infectious disease); therapeutic indications

Mesh:

Substances:

Year:  2019        PMID: 31377717      PMCID: PMC6685362          DOI: 10.1136/bcr-2019-229566

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  34 in total

1.  A sporadic outbreak of Burkholderia cepacia complex bacteremia in pediatric intensive care unit of a tertiary care hospital in coastal Karnataka, South India.

Authors:  Beena Antony; Elizabeth Varkey Cherian; Rekha Boloor; K Varadraj Shenoy
Journal:  Indian J Pathol Microbiol       Date:  2016 Apr-Jun       Impact factor: 0.740

Review 2.  Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review.

Authors:  Alessandra Monteiro Brodt; Elizabeth Stovold; Linjie Zhang
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

3.  Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.

Authors:  Aaron J Heffernan; Fekade B Sime; Jeffrey Lipman; Jayesh Dhanani; Katherine Andrews; David Ellwood; Keith Grimwood; Jason A Roberts
Journal:  Int J Antimicrob Agents       Date:  2018-11-23       Impact factor: 5.283

4.  Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.

Authors:  Francis J Gilchrist; A Kevin Webb; Rowland J Bright-Thomas; Andrew M Jones
Journal:  J Cyst Fibros       Date:  2012-05-01       Impact factor: 5.482

5.  Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis.

Authors:  D A Belchis; E Simpson; T Colby
Journal:  Mod Pathol       Date:  2000-04       Impact factor: 7.842

6.  Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

Authors:  L Dales; W Ferris; K Vandemheen; S D Aaron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-03       Impact factor: 3.267

7.  Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex.

Authors:  Karen Vermis; Tom Coenye; Eshwar Mahenthiralingam; Hans J Nelis; Peter Vandamme
Journal:  J Med Microbiol       Date:  2002-11       Impact factor: 2.472

8.  Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.

Authors:  Andrew McDowell; Eshwar Mahenthiralingam; Kerstin E A Dunbar; John E Moore; Mary Crowe; J Stuart Elborn
Journal:  J Med Microbiol       Date:  2004-07       Impact factor: 2.472

9.  Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study.

Authors:  Adam M Bressler; Keith S Kaye; John J LiPuma; Barbara D Alexander; Christopher M Moore; L Barth Reller; Christopher W Woods
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-29       Impact factor: 3.254

10.  Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.

Authors:  K De Boeck; A Malfroot; L Van Schil; P Lebecque; C Knoop; J R W Govan; C Doherty; S Laevens; P Vandamme
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.